- Home
- DXPE vs EWTX Comparison
DXPE vs EWTX Comparison
Compare DXPE & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXPE
- EWTX
- Stock Information
- Founded
- DXPE 1908
- EWTX 2017
- Country
- DXPE United States
- EWTX United States
- Employees
- DXPE N/A
- EWTX N/A
- Industry
- DXPE Industrial Machinery/Components
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- DXPE Industrials
- EWTX Health Care
- Exchange
- DXPE Nasdaq
- EWTX Nasdaq
- Market Cap
- DXPE 1.4B
- EWTX 1.2B
- IPO Year
- DXPE 1996
- EWTX 2021
- Fundamental
- Price
- DXPE $81.63
- EWTX $14.66
- Analyst Decision
- DXPE Buy
- EWTX Buy
- Analyst Count
- DXPE 1
- EWTX 8
- Target Price
- DXPE $95.00
- EWTX $40.13
- AVG Volume (30 Days)
- DXPE 91.6K
- EWTX 1.0M
- Earning Date
- DXPE 05-07-2025
- EWTX 05-08-2025
- Dividend Yield
- DXPE N/A
- EWTX N/A
- EPS Growth
- DXPE 33.22
- EWTX N/A
- EPS
- DXPE 4.81
- EWTX N/A
- Revenue
- DXPE $1,865,974,000.00
- EWTX N/A
- Revenue This Year
- DXPE $11.87
- EWTX N/A
- Revenue Next Year
- DXPE $3.57
- EWTX N/A
- P/E Ratio
- DXPE $17.09
- EWTX N/A
- Revenue Growth
- DXPE 11.94
- EWTX N/A
- 52 Week Low
- DXPE $43.25
- EWTX $10.60
- 52 Week High
- DXPE $107.06
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- DXPE 40.29
- EWTX 45.96
- Support Level
- DXPE $81.00
- EWTX $13.80
- Resistance Level
- DXPE $83.92
- EWTX $14.68
- Average True Range (ATR)
- DXPE 2.49
- EWTX 0.74
- MACD
- DXPE -0.78
- EWTX 0.12
- Stochastic Oscillator
- DXPE 9.38
- EWTX 52.92
About DXPE DXP Enterprises Inc.
DXP Enterprises Inc is a distributor of products and services to industrial customers in the United States, Canada, Mexico, and Dubai. The company's reportable segments include Service Centers, Innovative Pumping Solutions, and Supply Chain Services. It generates maximum revenue from the Service Centers segment. The company offers pumping solutions, supply chain services and maintenance, repair, operating, and production services for rotating equipment, bearings, power transmissions, industrial supplies, and safety products. It serves the General Industrial, Oil & Gas, Food & Beverage, Water & Wastewater, Chemical, Transportation, Aerospace & Others.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.